References
- Cooney, D O. Activated Charcoal in Medical Applications. New York: Marcel Dekker, 1995.
- Merigian, K S, Woodard, M, Hedges, J R, Roberts, J R, Stuebing, R, Rashkin, M C. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990; 8:479–483., [PUBMED], [INFOTRIEVE]
- Menzies, D G, Busuttil, A, Prescott, L F. Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:459–460.
- Kornberg, A E, Dolgin, J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med 1991; 20:648–651., [PUBMED], [INFOTRIEVE]
- Harchelroad, F, Cottington, E, Krenzelok, E P. Gastrointestinal transit times of a charcoal/sorbitol slurry in overdose patients. J Toxicol Clin Toxicol 1989; 27:91–99., [PUBMED], [INFOTRIEVE]
- McKinney, P, Phillips, S, Gomez, H F, Brent, J. Corneal abrasions secondary to activated charcoal therapy. Vet Hum Toxicol 1992; 34:336.
- Watson, W A, Litovitz, T L, Klein-Schwartz, W, Rodgers, G C Jr, Youniss, J, Reid, N, Rouse, W G, Rembert, R S, Borys, D, May, M E. 2003 Annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med 2004; 22:335–404., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Burke, G M, Wurster, D E, Berg, M J, Veng-Pedersen, P, Schottelius, D D. Surface characterization of activated charcoal by X-ray photoelectron spectroscopy: correlation with phenobarbital adsorption data. Pharm Res 1992; 9:126–130., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Otto, U, Stenberg, B. Drug adsorption properties of different activated charcoal dosage forms in vitro and in man. Svensk Farmaceutisk Tidskrift 1973; 77:613–615.
- McFarland, A KI, Chyka, P A. Selection of activated charcoal products for the treatment of poisonings. Ann Pharmacother 1993; 27:358–361., [PUBMED], [INFOTRIEVE]
- Cooney, D O. Evaluation of the US Pharmacopeia adsorption tests for activated charcoals and proposals for changes. Vet Hum Toxicol 1995; 37:371–377., [PUBMED], [INFOTRIEVE], [CSA]
- Neuvonen, P J, Olkkola, K T. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Med Toxicol Adverse Drug Exp 1988; 3:33–58., [PUBMED], [INFOTRIEVE]
- Muller, N F, Dessing, R P. European Drug Index. Alkmaar: Amsterdam Medical Press, 1997.
- Tsuchiya, T, Levy, G. Drug absorption efficacy of commercial activated charcoal tablets in vitro and in man. J Pharm Sci 1972; 61:624–625., [PUBMED], [INFOTRIEVE]
- Remmert, H P, Olling, M, Slob, W, van der Giesen, W F, van Dijk, A, Rauws, A G. Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers. Eur J Clin Pharmacol 1990; 39:501–505., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Decker, W J, Corby, D G. Activated charcoal adsorbs aflatoxin B1. Vet Hum Toxicol 1980; 22:388–389., [PUBMED], [INFOTRIEVE]
- Andersen, A H. Experimental studies on the pharmacology of activated charcoal. II. The effect of pH on the adsorption by charcoal from aqueous solutions. Acta Pharm 1947; 3:199–218.
- Watson, W A. Factors influencing the clinical efficacy of activated charcoal. Drug Intell Clin Pharm 1987; 21:160–166., [PUBMED], [INFOTRIEVE]
- Al-Shareef, A H, Buss, D C, Routledge, P A. Drug adsorption to charcoals and anionic binding resins. Human Exp Toxicol 1990; 9:95–97.
- Olkkola, K T. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man. Br J Clin Pharmacol 1985; 19:767–773., [PUBMED], [INFOTRIEVE]
- Tsuchiya, T, Levy, G. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro. J Pharm Sci 1972; 61:586–589., [PUBMED], [INFOTRIEVE]
- Chin, L, Picchioni, A L, Bourn, W M, Laird, H E. Optimal antidotal dose of activated charcoal. Toxicol Appl Pharmacol 1973; 26:103–108., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nakamura, T, Kawasaki, N, Matsumoto, K, Tanada, S. Effect of particle size on the adsorption of theophylline onto activated charcoal, in vitro study. Chudoku Kenkyu 2003; 16:57–62., [PUBMED], [INFOTRIEVE], [CSA]
- Hoegberg, L CG, Angelo, H R, Christophersen, A B, Christensen, H R. Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies. J Toxicol Clin Toxicol 2002; 40:59–67., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Guay, D RP, Meatherall, R C, Macaulay, P A, Yeung, C. Activated charcoal adsorption of diphenhydramine. Int J Clin Pharmacol Ther Toxicol 1984; 22:395–400., [PUBMED], [INFOTRIEVE]
- Neuvonen, P J, Kannisto, H, Lankinen, S. Capacity of two forms of activated charcoal to adsorb nefopam in vitro and to reduce its toxicity in vivo. J Toxicol Clin Toxicol 1984; 21:333–342.
- Rosenberg, J, Benowitz, N L, Pond, S. Pharmacokinetics of drug overdose. Clin Pharmacokinet 1981; 6:161–192., [PUBMED], [INFOTRIEVE]
- Yeates, P JA, Thomas, S HL. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Br J Clin Pharmacol 2000; 49:11–14., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laine, K, Kivistö, K T, Pelttari, S, Neuvonen, P J. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration. Pharmacol Toxicol 1996; 79:270–273., [PUBMED], [INFOTRIEVE], [CSA]
- Laine, K, Kivistö, K T, Neuvonen, P J. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. J Toxicol Clin Toxicol 1997; 35:263–268., [PUBMED], [INFOTRIEVE], [CSA]
- Laine, K, Kivistö, K T, Ojala-Karlsson, P, Neuvonen, P J. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion. Ther Drug Monit 1997; 19:46–50., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Green, R, Grierson, R, Sitar, D S, Tenenbein, M. How long after drug ingestion is activated charcoal still effective?. J Toxicol Clin Toxicol 2001; 39:601–605., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Christophersen, A B, Levin, D, Hoegberg, L CG, Angelo, H R, Kampmann, J P. Activated charcoal alone or after gastric lavage: a simulated large paracetamol intoxication. Br J Clin Pharmacol 2002; 53:312–317., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sato, R L, Wong, J J, Sumida, S M, Marn, R Y, Enoki, N R, Yamamoto, L G. Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose. Am J Emerg Med 2003; 21:189–191., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laine, K, Kivistö, K T, Laakso, I, Neuvonen, P J. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol 1997; 43:29–33., [PUBMED], [INFOTRIEVE], [CSA]
- Kirshenbaum, L A, Mathews, S C, Sitar, D S, Tenenbein, M. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989; 46:264–271., [PUBMED], [INFOTRIEVE]
- Roberts, J R, Gracely, E J, Schoffstall, J M. Advantage of high-surface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model. Acad Emerg Med 1997; 4:167–174., [PUBMED], [INFOTRIEVE], [CSA]
- Rangan, C, Nordt, S P, Hamilton, R, Ingels, M, Clark, R F. Treatment of acetaminophen ingestion with a superactivated charcoal-cola mixture. Ann Emerg Med 2001; 37:55–58., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kulig, K, Bar-Or, D, Cantrill, S V, Rosen, P, Rumack, B H. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985; 14:562–567., [PUBMED], [INFOTRIEVE]
- Albertson, T E, Derlet, R W, Foulke, G E, Minguillon, M C, Tharratt, S R. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of toxic ingestions. Ann Emerg Med 1989; 18:56–59., [PUBMED], [INFOTRIEVE]
- Bosse, G M, Barefoot, J A, Pfeifer, M P, Rodgers, G C. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med 1995; 13:203–209., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pond, S M, Lewis-Driver, D J, Williams, G M, Green, A C, Stevenson, N W. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 1995; 163:345–349., [PUBMED], [INFOTRIEVE], [CSA]
- Comstock, E G, Boisaubin, E V, Comstock, B S, Faulkner, T P. Assessment of the efficacy of activated charcoal following gastric lavage in acute drug emergencies. J Toxicol Clin Toxicol 1982; 19:149–165., [PUBMED], [INFOTRIEVE]
- Crome, P, Adams, R, Ali, C, Dallos, V, Dawling, S. Activated charcoal in tricyclic antidepressant poisoning: pilot controlled clinical trial. Human Toxicol 1983; 2:205–209.
- Hultén, B-A, Adams, R, Askenasi, R, Dallos, V, Dawling, S, Heath, A, Volans, G. Activated charcoal in tricyclic antidepressant poisoning. Human Toxicol 1988; 7:307–310., [CSA]
- Underhill, T J, Greene, M K, Dove, A F. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med 1990; 7:148–154., [PUBMED], [INFOTRIEVE]
- Buckley, N A, Whyte, I M, O'Connell, D L, Dawson, A H. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol 1999; 37:753–757., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Merigian, K S, Blaho, K E. Single-dose oral activated charcoal in the treatment of the self-poisoned patient: a prospective, randomized, controlled trial. Am J Ther 2002; 9:301–308., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Olson, K R. Is gut emptying all washed up?. Am J Emerg Med 1990; 8:560–561., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Whyte, I M, Buckley, N A. Progress in clinical toxicology: from case reports to toxicoepidemiology. Med J Aust 1995; 163:340–341., [PUBMED], [INFOTRIEVE], [CSA]
- Oderda, G M, Klein-Schwartz, W, Insley, B M. In vitro study of boric acid and activated charcoal. J Toxicol Clin Toxicol 1987; 25:13–19., [PUBMED], [INFOTRIEVE]
- Czajka, P A, Konrad, J D. Saline cathartics and the adsorptive capacity of activated charcoal for aspirin. Ann Emerg Med 1986; 15:548–551., [PUBMED], [INFOTRIEVE]
- Ryan, C F, Spigiel, R W, Zeldes, G. Enhanced adsorptive capacity of activated charcoal in the presence of magnesium citrate, N.F. J Toxicol Clin Toxicol 1980; 17:457–461.
- Van de Graaff, W B, Thompson, W L, Sunshine, I, Fretthold, D, Leickly, F, Dayton, H. Adsorbent and cathartic inhibition of enteral drug absorption. J Pharmacol Exp Ther 1982; 221:656–663., [PUBMED], [INFOTRIEVE]
- Nakamura, T, Oida, Y, Matsumoto, K, Kawasaki, N, Tanada, S. Inhibitory effect of sorbitol on acetaminophen adsorption by activated carbon. J Environ Sci Health Part A 2002; 37:905–912.
- Ofoefule, S I, Okonta, M. Adsorption studies of ciprofloxacin: evaluation of magnesium trisilicate, kaolin and starch as alternatives for the management of ciprofloxacin poisoning. Boll Chim Farm 1999; 138:239–242., [PUBMED], [INFOTRIEVE], [CSA]
- Ibezim, E C, Ofoefule, S I, Ejeahalaka, C NC, Orisakwe, O E. In vitro adsorption of ciprofloxacin on activated charcoal and talc. Am J Ther 1999; 6:199–201., [PUBMED], [INFOTRIEVE], [CSA]
- Andersen, A H. Experimental studies on the pharmacology of activated charcoal. I. Adsorption power of charcoal in aqueous solution. Acta Pharm 1946; 2:69–78.
- Lambert, R J, Kindler, B L, Schaeffer, D J. The efficacy of superactivated charcoal in treating rats exposed to a lethal oral dose of potassium cyanide. Ann Emerg Med 1988; 17:595–598., [PUBMED], [INFOTRIEVE]
- Belmouden, M, Assabbane, A, Ichou, Y A. Adsorption characteristics of a phenoxy acetic acid herbicide on activated carbon. J Environ Monit 2000; 2:257–260., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Orisakwe, O E, Ilondu, N A, Afonne, O J, Ofoefule, S I, Orish, C N. Acceleration of body clearance of diethylcarbamazine by oral activated charcoal. Pharmacol Res 2000; 42:167–170., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Afonne, O J, Orisakwe, O E, Ofuefule, S I, Tsalha, S, Obi, E, Ilondu, N A, Okorie, O. Saline cathartics and adsorptive capacity of activated charcoal for doxycycline. Acta Pol Pharm 2002; 59:177–179., [PUBMED], [INFOTRIEVE], [CSA]
- Smith, R P, Gosselin, R E, Henderson, J A, Anderson, D M. Comparison of the adsorptive properties of activated charcoal and Alaskan montmorillonite for some common poisons. Toxicol Appl Pharmacol 1967; 10:95–104., [PUBMED], [INFOTRIEVE], [CROSSREF]
- North, D S, Thompson, J D, Peterson, C D. Effect of activated charcoal on ethanol blood levels in dogs. Am J Hosp Pharm 1981; 38:864–866., [PUBMED], [INFOTRIEVE]
- Hultén, B-Å, Heath, A, Mellstrand, T, Hedner, T. Does alcohol absorb to activated charcoal? Human Toxicol 1985; 5:211–212.
- Neuvonen, P J, Olkkola, K T, Alanen, T. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man. Acta Pharm Toxicol 1984; 54:1–7.
- Olkkola, K T. Does ethanol modify antidotal efficacy of oral activated charcoal studies in vitro and in experimental animals. J Toxicol Clin Toxicol 1984; 22:425–432., [PUBMED], [INFOTRIEVE], [CSA]
- Tsitoura, A, Atta-Politou, J, Koupparis, M A. In vitro adsorption study of fluoxetine onto activated charcoal at gastric and intestinal pH using high performance liquid chromatography with fluorescence detector. J Toxicol Clin Toxicol 1997; 35:269–276., [PUBMED], [INFOTRIEVE], [CSA]
- Atta-Politou, J, Kolioliou, M, Havariotou, M, Koutselinis, A, Koupparis, M A. An in vitro evaluation of fluoxetine adsorption by activated charcoal and desorption upon addition of polyethylene glycol- electrolyte lavage solution. J Toxicol Clin Toxicol 1998; 36:117–124., [PUBMED], [INFOTRIEVE], [CSA]
- Atta-Politou, J, Skopelitis, I, Apatsidis, I, Koupparis, M. In vitro study on fluoxetine adsorption onto charcoal using potentiometry. Eur J Pharm Sci 2001; 12:311–319., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cooney, D O, Thomason, R. Adsorption of fluoxetine HCl by activated charcoal. J Pharm Sci 1997; 86:642–644., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chin, L, Picchioni, A L, Duplisse, B R. Comparative antidotaleffectiveness of activated charcoal, Arizona montmorillonite and evaporated milk. J Pharm Sci 1969; 58:1353–1356., [PUBMED], [INFOTRIEVE]
- Cooney, D O. In vitro evidence for ipecac inactivation by activated charcoal. J Pharm Sci 1978; 67:426–427., [PUBMED], [INFOTRIEVE]
- Freedman, G E, Pasternak, S, Krenzelok, E P. A clinical trial using syrup of ipecac and activated charcoal concurrently. Ann Emerg Med 1987; 16:164–166., [PUBMED], [INFOTRIEVE]
- Gomez, H F, McClafferty, H H, Flory, D, Brent, J, Dart, R C. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med 1997; 30:587–592., [PUBMED], [INFOTRIEVE], [CSA]
- Chyka, P A, Butler, A Y, Herman, M I. Ferrous sulfate adsorption by activated charcoal. Vet Hum Toxicol 2001; 43:11–13., [PUBMED], [INFOTRIEVE], [CSA]
- Ofoefule, S I, Onuoha, L C, Okonta, M J, Udeogaranya, P O, Orisakwe, O E. Effect of activated charcoal on isoniazid absorption in rabbits. Boll Chim Farm 2001; 140:183–186., [PUBMED], [INFOTRIEVE], [CSA]
- Favin, F D, Klein-Schwartz, W, Oderda, G M, Rose, S R. In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol 1988; 26:443–450., [PUBMED], [INFOTRIEVE]
- Linakis, J G, Lacouture, P G, Eisenberg, M S, Maher, T J, Lewander, W J, Driscoll, J L, Woolf, A D. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model. Pharmacol Toxicol 1989; 65:387–389., [PUBMED], [INFOTRIEVE]
- Chinouth, R W, Czajka, P A, Peterson, R G. N-acetylcysteine adsorption by activated charcoal. Vet Hum Toxicol 1980; 22:392–393., [PUBMED], [INFOTRIEVE]
- Klein-Schwartz, W, Oderda, G M. Adsorption of oral antidotes for acetaminophen poisoning (methionine and N-acetylcysteine) by activated charcoal. J Toxicol Clin Toxicol 1981; 18:283–290.
- Rybolt, T R, Burrelll, D E, Shults, J M, Kelley, A K. In vitro coadsorption of acetaminophen and N-acetylcysteine onto activated carbon powder. J Pharm Sci 1986; 75:904–906., [PUBMED], [INFOTRIEVE]
- North, D S, Peterson, C D, Krenzelok, E P. Effect of activated charcoal administration on acetylcysteine serum levels in humans. Am J Hosp Pharm 1981; 38:1022–1024., [PUBMED], [INFOTRIEVE]
- Renzi, F P, Donovan, J W, Martin, T G, Morgan, L, Harrison, E F. Concomitant use of activated charcoal and N-acetylcysteine. Ann Emerg Med 1985; 14:568–572., [PUBMED], [INFOTRIEVE]
- Ekins, B R, Ford, D C, Thompson, M IB, Bridges, R R, Rollins, D E, Jenkins, R D. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Am J Emerg Med 1987; 5:483–487., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Watson, W A, McKinney, P E. Activated charcoal and acetylcysteine absorption: issues in interpreting pharmacokinetic data. Ann Pharmacother 1991; 25:1081–1084.
- Tenenbein, P K, Sitar, D S, Tenenbein, M. Interaction between N-acetylcysteine and activated charcoal: implications for the treatment of acetaminophen poisoning. Pharmacotherapy 2001; 21:1331–1336., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Alegakis, A K, Tzatzarakis, M N, Tsatsakis, A M, Vlachonikolis, I G, Liakou, V. In vitro study of oxytetracycline adsorption on activated charcoal. J Environ Sci Health Part B 2000; 35:559–569., [CSA]
- Nakamura, T, Kawasaki, N, Tamura, T, Tanada, S. In vitro adsorption characteristics of paraquat and diquat with activated carbon varying in particle size. Bull Environ Contam Toxicol 2000; 64:377–382., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Idid, S Z, Lee, C Y. Effects of fuller's earth and activated charcoal on oral absorption of paraquat in rabbits. Clin Exp Pharmacol Physiol 1996; 23:679–681., [PUBMED], [INFOTRIEVE]
- Orisakwe, O E, Dioka, C E, Okpogba, A N, Orish, C N, Ofoefule, S I. Effect of activated charcoal on rifampicin absorption in man. Tokai J Exp Clin Med 1996; 21:51–54., [PUBMED], [INFOTRIEVE], [CSA]
- Hoffman, R S, Stringer, J A, Feinberg, R S, Goldfrank, L R. Comparative efficacy of thallium adsorption by activated charcoal, Prussian blue, and sodium polystyrene sulfonate. J Toxicol Clin Toxicol 1999; 37:833–837., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Raffa, R B, Wu, C, Stone, D J, Borenstein, M R, Codd, E E, Coogan, T P. Determination of the adsorption of tramadol hydrochloride by activated charcoal in vitro and in vivo. J Pharmacol Toxicol Methods 2000; 43:205–210., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sato, R L, Wong, J J, Sumida, S M, Yamamoto, L G. Adverse effects of superactivated charcoal administered to healthy volunteers. Hawaii Med J 2002; 61:251–253., [PUBMED], [INFOTRIEVE], [CSA]
- Pollack, M M, Dunbar, B S, Holbrook, P R, Fields, A I. Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528–529., [PUBMED], [INFOTRIEVE]
- Justiniani, F R, Hippalgaonkar, R, Martinez, L O. Charcoal-containing empyema complicating treatment for overdose. Chest 1985; 87:404–405., [PUBMED], [INFOTRIEVE]
- Elliott, C G, Colby, T V, Kelly, T M, Hicks, H G. Charcoal lung: bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672–674., [PUBMED], [INFOTRIEVE]
- Harris, C R, Filandrinos, D. Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470–1473., [PUBMED], [INFOTRIEVE]
- Silberman, H, Davis, S M, Lee, A. Activated charcoal aspiration. N C Med J 1990; 51:79–80., [PUBMED], [INFOTRIEVE]
- Lee, A GL, Wagner, F M, Chen, M.-F, Serrick, C, Giaid, A, Shennib, H. A novel charcoal-induced model of obliterative bronchiolitis-like lesions: implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis. J Thorac Cardiovasc Surg 1998; 115:822–827., [PUBMED], [INFOTRIEVE]
- Sabga, E, Dick, A, Lertzman, M, Tenenbein, M. Direct administration of charcoal into the lung and pleural cavity. Ann Emerg Med 1997; 30:695–697., [PUBMED], [INFOTRIEVE], [CSA]
- Thomas, B, Cummin, D, Falcone, R E. Accidental pneumothorax from a nasogastric tube. N Engl J Med 1996; 335:1325., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Caravati, E M, Knight, H H, Linscott, M S Jr, Stringham, J C. Esophageal laceration and charcoal mediastinum complicating gastric lavage. J Emerg Med 2001; 20:273–276., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Golej, J, Boigner, H, Burda, G, Hermon, M, Trittenwein, G. Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315–318., [PUBMED], [INFOTRIEVE], [CSA]
- Graff, G R, Stark, J, Berkenbosch, J W, Holcomb, G W III, Garola, R E. Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959–961., [PUBMED], [INFOTRIEVE]
- Arnold, T C, Willis, B H, Xiao, F, Conrad, S A, Carden, D L. Aspiration of activated charcoal elicits an increase in lung microvascular permeability. J Toxicol Clin Toxicol 1999; 37:9–16., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- George, D L, McLeod, R, Weinstein, R A. Contaminated commercial charcoal as a source of fungi in the respiratory tract. Infect Control Hosp Epidemiol 1991; 12:732–734., [PUBMED], [INFOTRIEVE]
- Moore, E W, Davies, M W. A black hole: an unexpected cause of difficult intubation. Anaesthesia 1996; 51:795–796., [PUBMED], [INFOTRIEVE], [CSA]
- Lopes de Freitas, J M, Ferreira, M G, Brito, M J. Charcoal deposits in the esophageal and gastric mucosa. Am J Gastroenterol 1997; 92:1359–1360., [PUBMED], [INFOTRIEVE]
- Crockett, R, Krishel, S J, Manoguerra, A, Williams, S R, Clark, R F. Prehospital use of activated charcoal: a pilot study. J Emerg Med 1996; 14:335–338., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Boyd, R, Hanson, J. Prospective single blinded randomised controlled trial of two orally administered activated charcoal preparations. J Accid Emerg Med 1999; 16:24–25., [PUBMED], [INFOTRIEVE], [CSA]
- Fischer, T FX, Singer, A J. Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial. Acad Emerg Med 1999; 6:895–899., [PUBMED], [INFOTRIEVE], [CSA]
- Galinsky, R E, Levy, G. Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate. J Toxicol Clin Toxicol 1984; 22:21–30., [PUBMED], [INFOTRIEVE]
- Levy, G, Houston, J B. Effect of activated charcoal on acetaminophen absorption. Pediatrics 1976; 58:432–435., [PUBMED], [INFOTRIEVE]
- McNamara, R M, Aaron, C K, Gemborys, M, Davidheiser, S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med 1989; 18:934–938., [PUBMED], [INFOTRIEVE]
- Neuvonen, P J, Vartiainen, M, Tokola, O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol 1983; 24:557–562., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yeates, P JA, Thomas, H A. Effect of delayed activated charcoal administration on paracetamol absorption after simulated overdose. Br J Clin Pharmacol 1999; 47:575P–602P., [CSA]
- Kivistö, K T, Neuvonen, P J. Effect of activated charcoal on the absorption of amiodarone. Human Exp Toxicol 1991; 10:327–329.
- Kärkkäinen, S, Neuvonen, P J. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH. Int J Clin Pharmacol Ther Toxicol 1986; 24:326–332.
- Tenenbein, M, Cohen, S, Sitar, D S. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal in acute drug overdose. Ann Emerg Med 1987; 16:838–841., [PUBMED], [INFOTRIEVE]
- Neuvonen, P J, Olkkola, K T. Effects of purgatives on antidotal efficacy of oral activated charcoal. Human Toxicol 1986; 5:255–263.
- Neuvonen, P J, Elonen, E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17:51–57., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Neuvonen, P J, Kivistö, K, Hirvisalo, E L. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Br J Clin Pharmacol 1988; 25:229–233., [PUBMED], [INFOTRIEVE]
- Neuvonen, P J, Kivistö, K T, Laine, K, Pyykkö, K. Prevention of chloroquine absorption by activated charcoal. Human Exp Toxicol 1992; 11:117–120.
- Neuvonen, P J, Kärkkäinen, S. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics. Clin Pharmacol Ther 1983; 33:386–393., [PUBMED], [INFOTRIEVE]
- Neuvonen, P J, Olkkola, K T. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent. J Toxicol Clin Toxicol 1984; 22:103–114., [PUBMED], [INFOTRIEVE]
- Torre, D, Sampietro, C, Quadrelli, C, Bianchi, W, Maggiolo, F. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers. Chemioterapia 1988; 7:382–386., [PUBMED], [INFOTRIEVE]
- Neuvonen, P J, Elfving, S M, Elonen, E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol 1978; 13:213–218., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Neuvonen, P J, Olkkola, K T. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man. Eur J Clin Pharmacol 1984; 26:761–767., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kivistö, K T, Neuvonen, P J. Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students. Br J Clin Pharmacol 1990; 30:496–498.
- Scolding, N, Ward, M J, Hutchings, A, Routledge, P A. Charcoal and isoniazid pharmacokinetics. Human Toxicol 1986; 5:285–286.
- Siefkin, A D, Albertson, T E, Corbett, M G. Isoniazid overdose pharmacokinetics and effects of oral charcoal in treatment. Human Toxicol 1987; 6:497–501., [CSA]
- El-Bahie, N, Allen, E M, Williams, J, Routledge, P A. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. Br J Clin Pharmacol 1985; 19:836–838., [PUBMED], [INFOTRIEVE]
- Olkkola, K T, Neuvonen, P J. Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 1984; 18:663–669., [PUBMED], [INFOTRIEVE]
- Laufen, H, Leitold, M. The effect of activated charcoal on the bioavailability of piroxicam in man. Int J Clin Pharmacol Ther Toxicol 1986; 24:48–52., [PUBMED], [INFOTRIEVE]
- Kärkkäinen, S, Neuvonen, P J. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics. Int J Clin Pharmacol Ther Toxicol 1985; 23:219–225.
- Mayersohn, M, Perrier, D, Picchioni, A L. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose. J Toxicol Clin Toxicol 1977; 11:561–567.
- Olkkola, K T, Neuvonen, P J. Effect of gastric pH on antidotal efficacy of activated charcoal in man. Int J Clin Pharmacol Ther Toxicol 1984; 22:565–569., [PUBMED], [INFOTRIEVE]
- Rosenberg, P J, Livingstone, D J, McLellan, B A. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal. Ann Emerg Med 1988; 17:681–683., [PUBMED], [INFOTRIEVE]
- Scholtz, E C, Jaffe, J M, Colaizzi, J L. Evaluation of five activated charcoal formulations for the inhibition of aspirin absorption and palatability in man. Am J Hosp Pharm 1978; 35:1355–1359., [PUBMED], [INFOTRIEVE]
- Easom, J M, Caraccio, T R, Lovejoy, F H Jr. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Clin Pharm 1982; 1:154–156., [PUBMED], [INFOTRIEVE]
- Sketris, I S, Mowry, J B, Czajka, P A, Anderson, W H, Stafford, D T. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal. J Clin Pharmacol 1982; 22:59–64., [PUBMED], [INFOTRIEVE]
- Danel, V, Henry, J A, Glucksman, E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J 1988; 296:1507.
- Juhl, R P. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption. Am J Hosp Pharm 1979; 36:1097–1098., [PUBMED], [INFOTRIEVE]
- Levy, G, Tsuchiya, T. Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther 1972; 13:317–322., [PUBMED], [INFOTRIEVE]
- Kärkkäinen, S, Neuvonen, P J. Effect of oral charcoal and urine pH on sotalol pharmacokinetics. Int J Clin Pharmacol Ther Toxicol 1984; 22:441–446.
- Akintonwa, A, Obodozie, O. Effect of activated charcoal on the disposition of sulphadoxine. Arch Int Pharmacodyn 1991; 309:185–192., [PUBMED], [INFOTRIEVE]
- Lim, D T, Singh, P, Nourtsis, S, Dela Cruz, R. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. Ann Emerg Med 1986; 15:1303–1307., [PUBMED], [INFOTRIEVE]
- Sintek, C, Hendeles, L, Weinberger, M. Inhibition of theophylline absorption by activated charcoal. J Pediatr 1979; 94:314–316., [PUBMED], [INFOTRIEVE]
- Cordonnier, J, Van Den Heede, M, Heyndrickx, A. Activated charcoal and ipecac syrup in prevention in tilidine absorption in man. Vet Hum Toxicol 1987; 29:105–106.
- Neuvonen, P J, Kannisto, H, Hirvisalo, E L. Effect of activated charcoal on absorption of tolbutamide and valproate in man. Eur J Clin Pharmacol 1983; 24:243–246., [PUBMED], [INFOTRIEVE], [CROSSREF]